辉宝动物保健 PAHC 深 沪
已收盘 08-01 16:00:00 美东时间
26.11
-0.390
-1.47%
华盛通- 最 高26.365
- 今 开26.12
- 成交量 35.65万股
- 最 低 25.58
- 昨 收 26.50
- 总市值 10.58亿
- 52周最高 31.80
- 市盈率 静 438.09
- 换手率 0.88%
- 52周最低 16.04
- 委 比 63.42%
- 总股本 4053.36万
- 历史最高 51.28
- 量 比 1.65
- 振 幅 2.96%
- 历史最低 8.56
- 每 手 1
- 风险率 4.17%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Insights into WAVE Life Sciences's Upcoming Earnings
WAVE Life Sciences (NASDAQ:WVE) is preparing to release its quarterly earnings ...
07-30 05:01
Phibro Animal Health Declares Quarterly Cash Dividend
The latest announcement is out from Phibro Animal Health ( ($PAHC) ). On July 2...
07-30 04:56
美股大行评级 | 潜在涨幅199.47%！杰富瑞上调Cogent Biosciences目标价至28美元，维持"买入"评级
今日重点评级关注：杰富瑞：维持Cogent Biosciences"买入"评级，目标价从23美元升至28美元；Leerink Partners：维持Cogent Biosciences"跑赢大市"评级，目标价从16美元升至18美元
07-08 09:34
Phibro's Feed Play Pays Off: JPMorgan Upgrades On Zoetis Deal Boost
Phibro Animal Health gains JPMorgan upgrade as analyst forecasts continued growth across key livestock products and long-term fundamentals.
07-08 02:30
This Constellation Brands Analyst Turns Bullish; Here Are Top 4 Upgrades For Monday
Top Wall Street analysts changed their outlook on these top names. For a comple...
07-07 20:24
JP Morgan Upgrades Phibro Animal Health to Overweight, Raises Price Target to $35
JP Morgan analyst Ekaterina Knyazkova upgrades Phibro Animal Health (NASDAQ:PAHC) from Neutral to Overweight and raises the price target from $25 to $35.
07-07 20:18
美股大行评级 | 潜在涨幅61.27%！Loop Capital上调英伟达目标价至250美元，维持"买入"评级
今日重点评级关注：Benchmark：维持特斯拉(TSLA)"买入"评级，目标价从350美元升至475美元>>
06-27 08:37
美股大行评级 | 潜在涨幅312.09%！HC Wainwright & Co.上调内克塔治疗目标价至120美元，维持"买入"评级
潜在涨幅312.09%！HC Wainwright & Co.上调内克塔治疗目标价至120美元，维持"买入"评级；联邦快递遭多家机构下调目标价>>
06-26 08:38
Morgan Stanley Maintains Equal-Weight on Phibro Animal Health, Raises Price Target to $26
Morgan Stanley analyst Erin Wright maintains Phibro Animal Health (NASDAQ:PAHC) with a Equal-Weight and raises the price target from $21 to $26.
06-26 00:31
Phibro Animal Health Raises FY2025 GAAP EPS Guidance from $0.96-$1.11 to $0.98-$1.11 vs $1.27 Est
Phibro Animal Health (NASDAQ:PAHC) raises FY2025 GAAP EPS guidance from $0.96-$1.11 to $0.98-$1.11 vs $1.27 analyst estimate..
05-08 04:33
